1. Home
  2. BCLI vs KDLY Comparison

BCLI vs KDLY Comparison

Compare BCLI & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • KDLY
  • Stock Information
  • Founded
  • BCLI 2000
  • KDLY 2019
  • Country
  • BCLI United States
  • KDLY United States
  • Employees
  • BCLI N/A
  • KDLY N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • KDLY
  • Sector
  • BCLI Health Care
  • KDLY
  • Exchange
  • BCLI Nasdaq
  • KDLY NYSE
  • Market Cap
  • BCLI 6.4M
  • KDLY 5.8M
  • IPO Year
  • BCLI N/A
  • KDLY 2024
  • Fundamental
  • Price
  • BCLI $1.21
  • KDLY $0.92
  • Analyst Decision
  • BCLI Strong Buy
  • KDLY
  • Analyst Count
  • BCLI 1
  • KDLY 0
  • Target Price
  • BCLI $30.00
  • KDLY N/A
  • AVG Volume (30 Days)
  • BCLI 118.2K
  • KDLY 418.2K
  • Earning Date
  • BCLI 11-14-2024
  • KDLY 11-12-2024
  • Dividend Yield
  • BCLI N/A
  • KDLY N/A
  • EPS Growth
  • BCLI N/A
  • KDLY N/A
  • EPS
  • BCLI N/A
  • KDLY N/A
  • Revenue
  • BCLI N/A
  • KDLY $2,875,400.00
  • Revenue This Year
  • BCLI N/A
  • KDLY N/A
  • Revenue Next Year
  • BCLI N/A
  • KDLY N/A
  • P/E Ratio
  • BCLI N/A
  • KDLY N/A
  • Revenue Growth
  • BCLI N/A
  • KDLY N/A
  • 52 Week Low
  • BCLI $1.05
  • KDLY $0.78
  • 52 Week High
  • BCLI $11.85
  • KDLY $4.20
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 23.69
  • KDLY N/A
  • Support Level
  • BCLI $1.05
  • KDLY N/A
  • Resistance Level
  • BCLI $1.95
  • KDLY N/A
  • Average True Range (ATR)
  • BCLI 0.20
  • KDLY 0.00
  • MACD
  • BCLI -0.00
  • KDLY 0.00
  • Stochastic Oscillator
  • BCLI 15.84
  • KDLY 0.00

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: